Hydrogen sulfide-mediated regulation of cell death signaling ameliorates adverse cardiac remodeling and diabetic cardiomyopathy

Sumit Kar, Tyler N. Kambis, Paras K. Mishra

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

The death of cardiomyocytes is a precursor for the cascade of hypertrophic and fibrotic remodeling that leads to cardiomyopathy. In diabetes mellitus (DM), the metabolic environment of hyperglycemia, hyperlipidemia, and oxidative stress causes cardiomyocyte cell death, leading to diabetic cardiomyopathy (DMCM), an independent cause of heart failure. Understanding the roles of the cell death signaling pathways involved in the development of cardiomyopathies is crucial to the discovery of novel targeted therapeutics and biomarkers for DMCM. Recent evidence suggests that hydrogen sulfide (H2S), an endogenous gaseous molecule, has cardioprotective effects against cell death. However, very little is known about signaling by which H2S and its downstream targets regulate myocardial cell death in the DM heart. This review focuses on H2S in the signaling of apoptotic, autophagic, necroptotic, and pyroptotic cell death in DMCM and other cardiomyopathies, abnormalities in H2S synthesis in DM, and potential H2S-based therapeutic strategies to mitigate myocardial cell death to ameliorate DMCM.

Original languageEnglish (US)
Pages (from-to)H1237-H1252
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume316
Issue number6
DOIs
StatePublished - Jan 1 2019

Fingerprint

Diabetic Cardiomyopathies
Hydrogen Sulfide
Cell Death
Cardiomyopathies
Diabetes Mellitus
Cardiac Myocytes
Autophagy
Hyperlipidemias
Hyperglycemia
Oxidative Stress
Heart Failure
Biomarkers
methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate
Therapeutics

Keywords

  • Apoptosis
  • Autophagy
  • Diabetes
  • Necroptosis
  • Pyroptosis
  • Therapeutic strategy

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Hydrogen sulfide-mediated regulation of cell death signaling ameliorates adverse cardiac remodeling and diabetic cardiomyopathy. / Kar, Sumit; Kambis, Tyler N.; Mishra, Paras K.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 316, No. 6, 01.01.2019, p. H1237-H1252.

Research output: Contribution to journalReview article

@article{b9c8eca819b54d12946b0f7f039e3dfb,
title = "Hydrogen sulfide-mediated regulation of cell death signaling ameliorates adverse cardiac remodeling and diabetic cardiomyopathy",
abstract = "The death of cardiomyocytes is a precursor for the cascade of hypertrophic and fibrotic remodeling that leads to cardiomyopathy. In diabetes mellitus (DM), the metabolic environment of hyperglycemia, hyperlipidemia, and oxidative stress causes cardiomyocyte cell death, leading to diabetic cardiomyopathy (DMCM), an independent cause of heart failure. Understanding the roles of the cell death signaling pathways involved in the development of cardiomyopathies is crucial to the discovery of novel targeted therapeutics and biomarkers for DMCM. Recent evidence suggests that hydrogen sulfide (H2S), an endogenous gaseous molecule, has cardioprotective effects against cell death. However, very little is known about signaling by which H2S and its downstream targets regulate myocardial cell death in the DM heart. This review focuses on H2S in the signaling of apoptotic, autophagic, necroptotic, and pyroptotic cell death in DMCM and other cardiomyopathies, abnormalities in H2S synthesis in DM, and potential H2S-based therapeutic strategies to mitigate myocardial cell death to ameliorate DMCM.",
keywords = "Apoptosis, Autophagy, Diabetes, Necroptosis, Pyroptosis, Therapeutic strategy",
author = "Sumit Kar and Kambis, {Tyler N.} and Mishra, {Paras K.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1152/ajpheart.00004.2019",
language = "English (US)",
volume = "316",
pages = "H1237--H1252",
journal = "American Journal of Physiology - Renal Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "6",

}

TY - JOUR

T1 - Hydrogen sulfide-mediated regulation of cell death signaling ameliorates adverse cardiac remodeling and diabetic cardiomyopathy

AU - Kar, Sumit

AU - Kambis, Tyler N.

AU - Mishra, Paras K.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The death of cardiomyocytes is a precursor for the cascade of hypertrophic and fibrotic remodeling that leads to cardiomyopathy. In diabetes mellitus (DM), the metabolic environment of hyperglycemia, hyperlipidemia, and oxidative stress causes cardiomyocyte cell death, leading to diabetic cardiomyopathy (DMCM), an independent cause of heart failure. Understanding the roles of the cell death signaling pathways involved in the development of cardiomyopathies is crucial to the discovery of novel targeted therapeutics and biomarkers for DMCM. Recent evidence suggests that hydrogen sulfide (H2S), an endogenous gaseous molecule, has cardioprotective effects against cell death. However, very little is known about signaling by which H2S and its downstream targets regulate myocardial cell death in the DM heart. This review focuses on H2S in the signaling of apoptotic, autophagic, necroptotic, and pyroptotic cell death in DMCM and other cardiomyopathies, abnormalities in H2S synthesis in DM, and potential H2S-based therapeutic strategies to mitigate myocardial cell death to ameliorate DMCM.

AB - The death of cardiomyocytes is a precursor for the cascade of hypertrophic and fibrotic remodeling that leads to cardiomyopathy. In diabetes mellitus (DM), the metabolic environment of hyperglycemia, hyperlipidemia, and oxidative stress causes cardiomyocyte cell death, leading to diabetic cardiomyopathy (DMCM), an independent cause of heart failure. Understanding the roles of the cell death signaling pathways involved in the development of cardiomyopathies is crucial to the discovery of novel targeted therapeutics and biomarkers for DMCM. Recent evidence suggests that hydrogen sulfide (H2S), an endogenous gaseous molecule, has cardioprotective effects against cell death. However, very little is known about signaling by which H2S and its downstream targets regulate myocardial cell death in the DM heart. This review focuses on H2S in the signaling of apoptotic, autophagic, necroptotic, and pyroptotic cell death in DMCM and other cardiomyopathies, abnormalities in H2S synthesis in DM, and potential H2S-based therapeutic strategies to mitigate myocardial cell death to ameliorate DMCM.

KW - Apoptosis

KW - Autophagy

KW - Diabetes

KW - Necroptosis

KW - Pyroptosis

KW - Therapeutic strategy

UR - http://www.scopus.com/inward/record.url?scp=85066163686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066163686&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00004.2019

DO - 10.1152/ajpheart.00004.2019

M3 - Review article

C2 - 30925069

AN - SCOPUS:85066163686

VL - 316

SP - H1237-H1252

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 0363-6127

IS - 6

ER -